In multiple models of neurodegenerative disease such as Alzheimer’s and Parkinson’s Diseases, inhibition of mTOR phosphorylation by rapamycin is correlated with improved neuronal viability [10], [34], [35]. Here, MTOR is linked to Parkinson disease.